Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
178.13
+1.13 (0.64%)
Oct 31, 2025, 3:00 PM CST
SHA:600436 Revenue
Zhangzhou Pientzehuang Pharmaceutical., had revenue of 2.06B CNY in the quarter ending September 30, 2025, a decrease of -26.28%. This brings the company's revenue in the last twelve months to 9.78B, down -10.35% year-over-year. In the year 2024, Zhangzhou Pientzehuang Pharmaceutical., had annual revenue of 10.79B with 7.25% growth.
Revenue (ttm)
9.78B
Revenue Growth
-10.35%
P/S Ratio
10.99
Revenue / Employee
3.44M
Employees
2,839
Market Cap
107.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.79B | 729.37M | 7.25% |
| Dec 31, 2023 | 10.06B | 1.36B | 15.69% |
| Dec 31, 2022 | 8.69B | 672.45M | 8.38% |
| Dec 31, 2021 | 8.02B | 1.51B | 23.20% |
| Dec 31, 2020 | 6.51B | 788.51M | 13.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |